Synopsys (Synopsys) Risk Assessment

View and export this data going back to 1992. Start your Free Trial

What is Synopsys Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Synopsys is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Synopsys's Risk Assessment

For the Software - Infrastructure subindustry, Synopsys's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synopsys's Risk Assessment Distribution in the Software Industry

For the Software industry and Technology sector, Synopsys's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Synopsys's Risk Assessment falls into.

Synopsys (NAS:SNPS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Synopsys Risk Assessment Related Terms

Thank you for viewing the detailed overview of Synopsys's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Synopsys (Synopsys) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Synopsys Inc (NAS:SNPS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

SNPS:Mexico SYPd:UK SYP:Germany SYP:Germany SYP:Germany S1NP34:Brazil

Address

675 Almanor Avenue, Sunnyvale, CA, USA, 94085

Website

https://www.synopsys.com

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Executives

Mercedes Johnson	director	MICRON TECHNOLOGY, INC, 8000 S FEDERAL WAY, MS 1-557, BOISE ID 83716
Richard S. Mahoney	officer: Chief Revenue Officer	2600 ANSYS DRIVE, CANONSBURG PA 15317
Runkel John F Jr	officer: General Counsel &	C/O INTUITIVE SURGICAL, INC., 1266 KIFER ROAD, SUNNYVALE CA 94086
Sudhindra Kankanwadi	officer: VP and Corporate Controller	690 E MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Robert G Painter	director	C/O TRIMBLE INC., 935 STEWART DRIVE, SUNNYVALE CA 94085
Geus Aart De	director, officer: Chairman of the Board & Co-CEO
Sassine Ghazi	officer: Chief Operating Officer	3075 W RAY ROAD, SUITE 528, THE PARK AT SAN TAN, CHANDLER AZ 85226
Shelagh Glaser	officer: CFO	ZENDESK, INC., 989 MARKET STREET, SAN FRANCISCO CA 94103
Roy Vallee	director	2211 S 47TH ST, PHOENIX AZ 85034
Joseph W Logan	officer: EVP, Sales & Corp Marketing	700 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Chrysostomos L Nikias	director	UNIVERSITY OF SOUTHERN CALIFORNIA, 3551 TROUSEDALE, BOVARD ADM 102, LOS ANGELES CA 90089-4019
Trac Pham	officer: CFO	700 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Luis Borgen	director	58 SUNSET RIDGE LANE, BOLTON MA 01740
Marc N Casper	director	C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Chi-foon Chan	director, officer: Co-CEO & President